Why Should You Put Biomarin Pharmaceutical Inc (NASDAQ: BMRN) On Your Portfolio?
Currently, there are 190.55M common shares owned by the public and among those 188.22M shares have been available to trade. The company’s stock has a 5-day price change of -0.83% and -3.46% over the past three months. BMRN shares are trading -30.90% year to date (YTD), with the 12-month market performance down to -30.75% lower. […]
Following The Money: Institution’s Growing Stake In Biomarin Pharmaceutical Inc (NASDAQ: BMRN)
Biomarin Pharmaceutical Inc (BMRN) concluded trading on Thursday at a closing price of $66.16, with 3.78 million shares of worth about $250.29 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -18.17% during that period and on December 05, 2024 the price saw a […]
